Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 13, Number 11, 2007

Articles

Favourites:
ADD
Favourites:
ADD

NAP and ADNF-9 Protect Normal and Down's Syndrome Cortical Neurons from Oxidative Damage and Apoptosis
pp. 1091-1098(8)
Authors: Busciglio, Jorge; Pelsman, Alejandra; Helguera, Pablo; Ashur-Fabian, Osnat; Pinhasov, Albert; Brenneman, Douglas E.; Gozes, Illana

Favourites:
ADD

Vasoactive Intestinal Peptide Receptors: A Molecular Target in Breast and Lung Cancer
pp. 1099-1104(6)
Authors: Moody, Terry W.; Gozes, Illana

Favourites:
ADD

PACAP in the Glucose and Energy Homeostasis: Physiological Role and Therapeutic Potential
pp. 1105-1112(8)
Authors: Nakata, Masanori; Yada, Toshihiko

Favourites:
ADD

Therapeutical Approaches of Vasoactive Intestinal Peptide as a Pleiotropic Immunomodulator
pp. 1113-1139(27)
Authors: Gonzalez-Rey, Elena; Varela, Nieves; Chorny, Alejo; Delgado, Mario

Favourites:
ADD

Carotid Artery Atherosclerosis: What is the Evidence for Drug Action?
pp. 1141-1159(19)
Authors: Daskalopoulou, Stella S.; Daskalopoulos, Marios E.; Perrea, Despina; Nicolaides, Andrew N.; Liapis, Christos D.

Favourites:
ADD
Favourites:
ADD

Magnetic Carriers: A Promising Device for Targeting Drugs Into the Human Body
pp. 1179-1185(7)
Authors: A. Silva, A. K.; Silva, E. L.; Carrico, A. S.; T. Egito, E. S.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content